Loading...
The drug companies Bayer and Novartis have threatened to take the NHS to court over a new policy to offer patients with wet age-related macular degeneration a choice of drugs to treat their condition, including details of price. Twelve CCGs across northeast England and Cumbria are facing judicial review because they are planning to offer...
Last updated: Jan 7, 2026